European Companies Search Engine

EU funding (€260,348): DuoLipo-TNP: Dual-Responsive Liposome Platform for Selective Delivery of Triphosphate Nucleotide Prodrugs in Triple-Negative Breast Cancer Hor 27 Feb 2026 EU Research and Innovation programme "Horizon"

Overview

Text

This publication is not available.

The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Fundação Gimm - Gulbenkian Institute For Molecular Medicine, Lisbon, Portugal.